These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24137741)

  • 1. Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases. Study first to use 'structural' approach in hunt for amyloid-inhibiting agents.
    Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):642-3. PubMed ID: 24137741
    [No Abstract]   [Full Text] [Related]  

  • 2. Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation.
    Windsor PK; Plassmeyer SP; Mattock DS; Bradfield JC; Choi EY; Miller BR; Han BH
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.
    Bu XL; Rao PPN; Wang YJ
    Mol Neurobiol; 2016 Aug; 53(6):3565-3575. PubMed ID: 26099310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural studies of amyloid fibrils and senile plaques in human brain.
    Miyakawa T; Katsuragi S; Watanabe K; Shimoji A; Ikeuchi Y
    Acta Neuropathol; 1986; 70(3-4):202-8. PubMed ID: 2945355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue.
    Kollmer M; Close W; Funk L; Rasmussen J; Bsoul A; Schierhorn A; Schmidt M; Sigurdson CJ; Jucker M; Fändrich M
    Nat Commun; 2019 Oct; 10(1):4760. PubMed ID: 31664019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: from pathology to therapeutic approaches.
    Jakob-Roetne R; Jacobsen H
    Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of Nitraria retusa extract and its constituent isorhamnetin against amyloid β-induced cytotoxicity and amyloid β aggregation.
    Iida A; Usui T; Zar Kalai F; Han J; Isoda H; Nagumo Y
    Biosci Biotechnol Biochem; 2015; 79(9):1548-51. PubMed ID: 25965116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques.
    Merz PA; Wisniewski HM; Somerville RA; Bobin SA; Masters CL; Iqbal K
    Acta Neuropathol; 1983; 60(1-2):113-24. PubMed ID: 6683919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of amyloid filaments in Alzheimer's disease and the unconventional virus infections of the nervous system.
    Masters CL; Beyreuther K
    Psychol Med; 1986 Nov; 16(4):735-7. PubMed ID: 3547446
    [No Abstract]   [Full Text] [Related]  

  • 12. Insights into the Effect of Curcumin and (-)-Epigallocatechin-3-Gallate on the Aggregation of Aβ(1-40) Monomers by Means of Molecular Dynamics.
    Tavanti F; Pedone A; Menziani MC
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to alter the progression of Alzheimer's disease.
    Siman R; Scott RW
    Curr Opin Biotechnol; 1996 Dec; 7(6):601-7. PubMed ID: 8939637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief overview of amyloids and Alzheimer's disease.
    Ow SY; Dunstan DE
    Protein Sci; 2014 Oct; 23(10):1315-31. PubMed ID: 25042050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.
    Lu JX; Qiang W; Yau WM; Schwieters CD; Meredith SC; Tycko R
    Cell; 2013 Sep; 154(6):1257-68. PubMed ID: 24034249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Storck SE; Pietrzik CU
    Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis.
    Tolar M; Abushakra S; Sabbagh M
    Alzheimers Dement; 2020 Nov; 16(11):1553-1560. PubMed ID: 31706733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.
    Lowe SL; Duggan Evans C; Shcherbinin S; Cheng YJ; Willis BA; Gueorguieva I; Lo AC; Fleisher AS; Dage JL; Ardayfio P; Aguiar G; Ishibai M; Takaichi G; Chua L; Mullins G; Sims JR
    J Prev Alzheimers Dis; 2021; 8(4):414-424. PubMed ID: 34585215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.